Chronic inflammation; Metabolic syndrome; Osteoarthritis; Personalized treatment; Systemic; Humans; Inflammation; Pain; Obesity; Quality of Life; Geriatrics and Gerontology; Aging
Abstract :
[en] Osteoarthritis (OA) is a disease with systemic implications that go beyond joint problems. Its pathogenic mechanisms involve a variety of systemic conditions that contribute to joint damage. These include metabolic dysfunction, chronic low-grade inflammation, neuroplastic pain, and the influence of the central nervous system in the development of neuropathic pain. Besides, OA can negatively affect other aspects of health, such as quality of life, reduced physical activity, social isolation, depression, and anxiety. OA can be considered a complex system in which pathological interactions involve not only obesity and metabolic dysfunction, but also fragility syndrome, sarcopenia, neurological complications, and systemic energy redistribution. Complex systems are composed of multiple interacting and dynamic parts and exhibit emergent properties that cannot be fully explained by examining their individual components. Chronic low-grade inflammation is characteristic of OA, occurring both in the affected joint, and systemically, mainly due to adipose tissue inflammation in obese patients. Obesity is a key factor in the progression of OA, so primary treatment should focus on its control, while maintaining muscle health. The chronic inflammation could lead to changes in energy distribution among the affected joint tissues. Therefore, OA should be approached as a systemic disease, considering individual patient factors, such as genetics, inflammatory response, and lifestyle. Medical care should be more holistic and personalized. Consideration of a name change, such as "systemic OA", could help to move away from the perception of a disease focused only on the joints.
Disciplines :
Public health, health care sciences & services
Author, co-author :
Herrero-Beaumont, Gabriel ; Bone and Joint Research Unit, Rheumatology Dept, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain. gherrero@fjd.es
Castro-Dominguez, Francisco ; Rheumatology Department, Teknon Medical Center, Quironsalud Group, Barcelona, Spain
Migliore, Alberto; Rheumatology Unit, San Pietro Fatebenefratelli Hospital, Rome, Italy
Naredo, Esperanza ; Bone and Joint Research Unit, Rheumatology Dept, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain
Largo, Raquel ; Bone and Joint Research Unit, Rheumatology Dept, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique
Language :
English
Title :
Systemic osteoarthritis: the difficulty of categorically naming a continuous condition.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
S. Castañeda J.A. Roman-Blas R. Largo G. Herrero-Beaumont Osteoarthritis: a progressive disease with changing phenotypes Rheumatol (Oxford) 2014 53 1 3 10.1093/rheumatology/ket247
S.M. Bierma-Zeinstra M. Van Middelkoop Osteoarthritis: In search of phenotypes Nat Rev Rheumatol 2017 13 705 706 10.1038/NRRHEUM.2017.181 29097813
G. Aubourg S.J. Rice P. Bruce-Wootton J. Loughlin Genetics of osteoarthritis Osteoarthrit Cartil 2022 30 636 649 1:STN:280:DC%2BB3sjnvVCrsQ%3D%3D 10.1016/J.JOCA.2021.03.002
J. Loughlin Translating osteoarthritis genetics research: challenging times ahead Trends Mol Med 2022 28 176 182 10.1016/J.MOLMED.2021.12.007 35033441
A. Batushansky S. Zhu R.K. Komaravolu et al. Fundamentals of OA. an initiative of osteoarthritis and cartilage. obesity and metabolic factors in OA Osteoarthrit Cartil 2022 30 501 515 1:STN:280:DC%2BB2crptVKmtQ%3D%3D 10.1016/J.JOCA.2021.06.013
A. Mobasheri M.P. Rayman O. Gualillo et al. The role of metabolism in the pathogenesis of osteoarthritis Nat Rev Rheumatol 2017 10.1038/nrrheum.2017.50 28381830
H. Long R. Cao H. Yin et al. Associations between obesity, diabetes mellitus, and cardiovascular disease with progression states of knee osteoarthritis (KOA) Aging Clin Exp Res 2023 35 333 340 10.1007/S40520-022-02312-8 36525243
K. Fu S.R. Robbins J.J. McDougall Osteoarthritis: the genesis of pain Rheumatology (Oxford) 2018 10.1093/RHEUMATOLOGY/KEX419 30060225
T.W. O’Neill M.J.M. Parkes N. Maricar et al. Synovial tissue volume: a treatment target in knee osteoarthritis (OA) Ann Rheum Dis 2016 10.1136/annrheumdis-2014-206927 27143653
F. Berenbaum T.M. Griffin R. Liu-Bryan Review: metabolic regulation of inflammation in osteoarthritis Arthr and Rheumatol 2017 69 9 21 10.1002/art.39842
A. Dell’Isola K. Pihl A. Turkiewicz et al. Risk of comorbidities following physician-diagnosed knee or hip osteoarthritis: a register-based cohort study Arthr Care Res (Hoboken) 2022 74 1689 1695 10.1002/ACR.24717
D. Fonseca-Rodrigues A. Rodrigues T. Martins et al. Correlation between pain severity and levels of anxiety and depression in osteoarthritis patients: a systematic review and meta-analysis Rheumatol (Oxford) 2021 61 53 75 10.1093/RHEUMATOLOGY/KEAB512
N. Veronese G. Honvo O. Bruyère et al. Knee osteoarthritis and adverse health outcomes: an umbrella review of meta-analyses of observational studies Aging Clin Exp Res 2023 35 245 252 10.1007/S40520-022-02289-4 36331799
N. Veronese B. Stubbs M. Solmi et al. Osteoarthristis increases the risk of cardiovascular disease: data from the osteoarthritis initiative J Nutr Health Aging 2018 22 371 376 1:STN:280:DC%2BC1MrlslSjtg%3D%3D 10.1007/S12603-017-0941-0 29484350
A.V. Perruccio S. Zahid C. Yip et al. Cardiovascular Risk Profile and Osteoarthritis-Considering Sex and Multisite Joint Involvement: A Canadian Longitudinal Study on Aging Arthr Care Res (Hoboken) 2023 75 893 901 1:CAS:528:DC%2BB38XjtVWlurrL 10.1002/ACR.24826
K.M. Leyland L.S. Gates M.T. Sanchez-Santos et al. Knee osteoarthritis and time-to all-cause mortality in six community-based cohorts: an international meta-analysis of individual participant-level data Aging Clin Exp Res 2021 33 529 545 10.1007/S40520-020-01762-2 33590469 7943431
G. Herrero-Beaumont S. Pérez-Baos O. Sánchez-Pernaute et al. Targeting chronic innate inflammatory pathways, the main road to prevention of osteoarthritis progression Biochem Pharmacol 2019 165 24 32 1:CAS:528:DC%2BC1MXktFegsrk%3D 10.1016/j.bcp.2019.02.030 30825432
K. Li X. Ji R. Seeley et al. Impaired glucose metabolism underlies articular cartilage degeneration in osteoarthritis FASEB J 2022 10.1096/FJ.202200485R 36421020
S. Stücker M. Bollmann C. Garbers J. Bertrand The role of calcium crystals and their effect on osteoarthritis pathogenesis Best Pract Res Clin Rheumatol 2021 10.1016/J.BERH.2021.101722 34732285
I. Atukorala C.K.C. Kwoh A. Guermazi et al. Synovitis in knee osteoarthritis: a precursor of disease? Ann Rheum Dis 2016 10.1136/annrheumdis-2014-205894 25488799
E. Sanchez-Lopez R. Coras A. Torres et al. Synovial inflammation in osteoarthritis progression Nat Rev Rheumatol 2022 10.1038/s41584-022-00749-9 35165404 9050956
J.A. Roman-Blas S. Castañeda R. Largo G. Herrero-Beaumont Osteoarthritis associated with estrogen deficiency Arthritis research therapy 2009 11 241 10.1186/ar2791 19804619 2787275
P. Cilliers Complexity and Postmodernism, ISBN 0-415-15286-0 1998 London Routledge
J. Niu M. Clancy P. Aliabadi et al. Metabolic syndrome, its components, and knee osteoarthritis: the framingham osteoarthritis study Arthr and Rheumatol 2017 69 1194 1203 10.1002/art.40087
E. Thijssen A. Van Caam P.M. Van Der Kraan Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis Rheumatol (Oxford) 2015 10.1093/RHEUMATOLOGY/KEU464
K.H. Collins K.L. Lenz E.N. Pollitt et al. Adipose tissue is a critical regulator of osteoarthritis Proc Natl Acad Sci U S A 2021 10.1073/pnas.2021096118 34810238 8670525
N.S. Harasymowicz N.D. Clement A. Azfer et al. Regional differences between perisynovial and infrapatellar adipose tissue depots and their response to class II and class III obesity in patients With osteoarthritis Arthr and Rheumatol 2017 69 1396 1406 1:CAS:528:DC%2BC2sXhtVygu7fN 10.1002/art.40102
R. Liu-Bryan R. Terkeltaub Emerging regulators of the inflammatory process in osteoarthritis Nat Rev Rheumatol 2014 10.1038/nrrheum.2014.162 25266449 4374654
E.V. Tchetina G.A. Markova Regulation of energy metabolism in the growth plate and osteoarthritic chondrocytes Rheumatol Int 2018 38 1963 1974 1:CAS:528:DC%2BC1cXhtlGlsLnF 10.1007/s00296-018-4103-4 30019225
P. Gratal A. Lamuedra J.P. Medina et al. Purinergic system signaling in metainflammation-associated osteoarthritis Front Med (Lausanne) 2020 10.3389/FMED.2020.00506 32984382
R. Largo L. Tardío J. Andrés-Bergós G. Herrero-Beaumont Study of the O-linked-N-acetyl-glucosaminylation of proteins induced by high doses of glucosamine and its correlation with osteoarthritis progression Osteoarthr Cartil 2012 20 S126 10.1016/j.joca.2012.02.160
G. Herrero-Beaumont R. Largo Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation? Ann Rheum Dis 2020 79 1261 1263 1:CAS:528:DC%2BB3cXitFaks7zO 10.1136/annrheumdis-2020-217454 32554393
S.C. Rosa A.T. Rufino F. Judas et al. Expression and function of the insulin receptor in normal and osteoarthritic human chondrocytes: modulation of anabolic gene expression, glucose transport and GLUT-1 content by insulin Osteoarthr Cartil 2011 19 719 727 1:STN:280:DC%2BC3MrisVCqtw%3D%3D 10.1016/J.JOCA.2011.02.004
E.V. Tchetina G.A. Markova A.R. Poole et al. Deferoxamine suppresses collagen cleavage and protease, cytokine, and COL10A1 expression and upregulates ampk and krebs cycle genes in human osteoarthritic cartilage Int J Rheumatol 2016 10.1155/2016/6432867 28042296 5155111
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.